| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018 | 499 | 2018 |
| High rate of recurrent de novo mutations in developmental and epileptic encephalopathies FF Hamdan, CT Myers, P Cossette, P Lemay, D Spiegelman, AD Laporte, ... The American Journal of Human Genetics 101 (5), 664-685, 2017 | 401 | 2017 |
| Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia K Tuschl, E Meyer, LE Valdivia, N Zhao, C Dadswell, A Abdul-Sada, ... Nature communications 7 (1), 11601, 2016 | 276 | 2016 |
| Immune therapy in autoimmune encephalitis: a systematic review M Nosadini, SS Mohammad, S Ramanathan, F Brilot, RC Dale Expert review of neurotherapeutics 15 (12), 1391-1419, 2015 | 236 | 2015 |
| Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review VX Han, S Patel, HF Jones, TC Nielsen, SS Mohammad, MJ Hofer, ... Translational psychiatry 11 (1), 71, 2021 | 231 | 2021 |
| Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia E Meyer, KJ Carss, J Rankin, JME Nichols, D Grozeva, AP Joseph, ... Nature genetics 49 (2), 223-237, 2017 | 214 | 2017 |
| Autoimmune encephalitis: recent updates and emerging challenges S Ramanathan, SS Mohammad, F Brilot, RC Dale Journal of Clinical Neuroscience 21 (5), 722-730, 2014 | 211 | 2014 |
| Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N‐Methyl‐D‐aspartate receptor or dopamine‐2 receptor SS Mohammad, K Sinclair, S Pillai, V Merheb, TD Aumann, D Gill, ... Movement Disorders 29 (1), 117-122, 2014 | 197 | 2014 |
| Herpes simplex virus‐induced anti‐N‐methyl‐d‐aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases M Nosadini, SS Mohammad, F Corazza, EM Ruga, K Kothur, G Perilongo, ... Developmental Medicine & Child Neurology 59 (8), 796-805, 2017 | 170 | 2017 |
| Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children HL Teoh, SS Mohammad, PN Britton, T Kandula, MS Lorentzos, R Booy, ... JAMA neurology 73 (3), 300-307, 2016 | 123 | 2016 |
| Utility of CSF cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis K Kothur, L Wienholt, SS Mohammad, EM Tantsis, S Pillai, PN Britton, ... PLoS One 11 (8), e0161656, 2016 | 111 | 2016 |
| GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome FR Danti, S Galosi, M Romani, M Montomoli, KJ Carss, FL Raymond, ... Neurology: Genetics 3 (2), e143, 2017 | 102 | 2017 |
| Movement disorders in children with anti‐NMDAR encephalitis and other autoimmune encephalopathies SS Mohammad, VSC Fung, P Grattan‐Smith, D Gill, S Pillai, ... Movement disorders 29 (12), 1539-1542, 2014 | 86 | 2014 |
| The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study JA Varley, AJS Webb, B Balint, VSC Fung, KD Sethi, MAJ Tijssen, T Lynch, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (6), 724-726, 2019 | 83 | 2019 |
| Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder M Nosadini, G Alper, CJ Riney, LA Benson, SS Mohammad, ... Neuroimmunology & Neuroinflammation 3 (1), e188, 2016 | 82 | 2016 |
| Evaluation of oxidant and antioxidant status in term neonates: a plausible protective role of bilirubin M Shekeeb Shahab, P Kumar, N Sharma, A Narang, R Prasad Molecular and cellular biochemistry 317, 51-59, 2008 | 73 | 2008 |
| Symptomatic treatment of children with anti‐NMDAR encephalitis SS Mohammad, H Jones, M Hong, M Nosadini, C Sharpe, SC Pillai, ... Developmental Medicine & Child Neurology 58 (4), 376-384, 2016 | 70 | 2016 |
| Postencephalitic epilepsy and drug‐resistant epilepsy after infectious and antibody‐associated encephalitis in childhood: clinical and etiologic risk factors SC Pillai, SS Mohammad, Y Hacohen, E Tantsis, K Prelog, EH Barnes, ... Epilepsia 57 (1), e7-e11, 2016 | 70 | 2016 |
| KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation L Cif, D Demailly, JP Lin, KE Barwick, M Sa, L Abela, S Malhotra, ... Brain 143 (11), 3242-3261, 2020 | 68 | 2020 |
| GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS M Waak, SS Mohammad, D Coman, K Sinclair, L Copeland, P Silburn, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 221-222, 2018 | 60 | 2018 |
Russell C DaleUniversity of SydneyVerified email at health.nsw.gov.au
